Perceptions of Palliative Care in Phase 1 Cancer Trials Vs 1

  • Research type

    Research Study

  • Full title

    A study of the perceptions of palliative care in cancer patients who are entering a phase 1 clinical trial

  • IRAS ID

    189567

  • Contact name

    Janelle Yorke

  • Contact email

    janelle.yorke@manchester.ac.uk

  • Sponsor organisation

    University of Manchester

  • Duration of Study in the UK

    0 years, 5 months, 3 days

  • Research summary

    The role of palliative care is evolving from a traditional model of end of life care to one of earlier intervention, with an evidence base for the benefits of palliative care on quality of life and survival now emerging. For patients with cancer this ideally demands integration of palliative care services concurrently alongside active oncology treatment. This model of care should include phase 1 cancer clinical trials which are a key aspect of oncology treatment for patients with advanced cancer who often have stopped responding to or are not suitable for standard treatment. Patients entering phase 1 trials are unique as they have advanced disease but a good level of function and there is so far a lack of research on their desire and need for palliative care. If integration of palliative care services is to be successful it needs to be relevant and acceptable to patients and a better understanding of patients’ perceptions of palliative care within phase 1 cancer trials is needed and is the aim of this piece of research. The Christie has a leading Phase 1 Clinical Trials Unit as part of the Manchester Experimental Cancer Medicine Centre and is currently developing its palliative and supportive care services within the unit.

    This is a qualitative study of the perceptions of palliative care in cancer patients who are entering a phase 1 clinical trial. The study will aim to conduct single semi-structured interviews with approximately 12 patients who have been deemed eligible for participation in or have recently commenced a phase 1 clinical trial at The Christie. Participants will be recruited from the phase 1 new patient and trial clinics. The interviews will be recorded and using thematic analysis the main emerging themes will be reported. The study is sponsored by the University of Manchester.

  • REC name

    North West - Liverpool Central Research Ethics Committee

  • REC reference

    15/NW/0877

  • Date of REC Opinion

    11 Nov 2015

  • REC opinion

    Favourable Opinion